SG Americas Securities’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,508
| Closed | -$123K | – | 3110 |
|
|
2024
Q4 | $123K | Buy |
14,508
+1,319
| +10% | +$11.2K | ﹤0.01% | 2300 |
|
|
2024
Q3 | $153K | Buy |
+13,189
| New | +$153K | ﹤0.01% | 2415 |
|
|
2024
Q2 | – | Sell |
-12,082
| Closed | -$143K | – | 2625 |
|
|
2024
Q1 | $143K | Sell |
12,082
-125,735
| -91% | -$1.49M | ﹤0.01% | 2000 |
|
|
2023
Q4 | $1.69M | Buy |
137,817
+6,670
| +5% | +$81.7K | 0.02% | 674 |
|
|
2023
Q3 | $1.26M | Buy |
131,147
+9,794
| +8% | +$94.3K | 0.01% | 1003 |
|
|
2023
Q2 | $1.09M | Buy |
+121,353
| New | +$1.09M | 0.01% | 915 |
|
|
2023
Q1 | – | Sell |
-15,734
| Closed | -$106K | – | 3067 |
|
|
2022
Q4 | $106K | Sell |
15,734
-823
| -5% | -$5.55K | ﹤0.01% | 2435 |
|
|
2022
Q3 | $240K | Sell |
16,557
-134
| -0.8% | -$1.94K | ﹤0.01% | 1925 |
|
|
2022
Q2 | $164K | Buy |
+16,691
| New | +$164K | ﹤0.01% | 2552 |
|
|
2022
Q1 | – | Sell |
-11,956
| Closed | -$158K | – | 2789 |
|
|
2021
Q4 | $158K | Sell |
11,956
-6,042
| -34% | -$79.8K | ﹤0.01% | 2518 |
|
|
2021
Q3 | $314K | Sell |
17,998
-5,092
| -22% | -$88.8K | ﹤0.01% | 2670 |
|
|
2021
Q2 | $553K | Buy |
23,090
+678
| +3% | +$16.2K | ﹤0.01% | 1708 |
|
|
2021
Q1 | $576K | Buy |
22,412
+16,936
| +309% | +$435K | ﹤0.01% | 1751 |
|
|
2020
Q4 | $104K | Buy |
+5,476
| New | +$104K | ﹤0.01% | 2661 |
|
|
2016
Q1 | – | Sell |
-871
| Closed | -$44K | – | 2614 |
|
|
2015
Q4 | $44K | Sell |
871
-453
| -34% | -$22.9K | ﹤0.01% | 2110 |
|
|
2015
Q3 | $66K | Buy |
+1,324
| New | +$66K | ﹤0.01% | 1938 |
|